Literature DB >> 30203323

Overexpressed TTC3 Protein Tends to be Cleaved into Fragments and Form Aggregates in the Nucleus.

Yueqing Gong1,2,3, Kun Wang1,2,3, Sheng-Ping Xiao1,2,3, Panying Mi1,2,3, Wanjie Li2, Yu Shang2, Fei Dou4,5,6.   

Abstract

Human tetratricopeptide repeat domain 3 (TTC3) is a gene on 21q22.2 within the Down syndrome critical region (DSCR). Earlier studies suggest that TTC3 may be an important regulator in individual development, especially in neural development. As an E3 ligase, TTC3 binds to phosphorylated Akt and silence its activity via proteasomal cascade. Several groups also reported the involvement of TTC3 in familial Alzheimer's disease recently. In addition, our previous work shows that TTC3 also regulates the degradation of DNA polymerase gamma and over-expressed TTC3 protein tends to form insoluble aggregates in cells. In this study, we focus on the solubility and intracellular localization of TTC3 protein. Over-expressed TTC3 tends to form insoluble aggregates over time. The proteasome inhibitor MG132 treatment resulted in more TTC3 aggregates in a short period of time. We fused the fluorescent protein to either terminus of the TTC3 protein and found that the intracellular localization of fluorescent signals are different between the N-terminal tagged and C-terminal tagged proteins. Western blotting revealed that the TTC3 protein is cleaved into fragments of different sizes at multiple sites. The N-terminal sub-fragments of TTC3 are prone to from nuclear aggregates and the TTC3 nuclear import is mediated by signals within the N-terminal 1 to 650 residues. Moreover, over-expressed TTC3 induced a considerable degree of cytotoxicity, and its N-terminal sub-fragments are more potent inhibitors of cell proliferation than full-length protein. Considering the prevalent proteostasis dysregulation in neurodegenerative diseases, these findings may relate to the pathology of such diseases.

Entities:  

Keywords:  Aggregation; Alzheimer’s disease; Down syndrome; Nuclear localization signal; Proteotoxicity; TTC3

Year:  2018        PMID: 30203323     DOI: 10.1007/s12017-018-8509-7

Source DB:  PubMed          Journal:  Neuromolecular Med        ISSN: 1535-1084            Impact factor:   3.843


  28 in total

1.  Regional and cellular specificity of the expression of TPRD, the tetratricopeptide Down syndrome gene, during human embryonic development.

Authors:  M Rachidi; C Lopes; S Gassanova; P M Sinet; M Vekemans; T Attie; A L Delezoide; J M Delabar
Journal:  Mech Dev       Date:  2000-05       Impact factor: 1.882

Review 2.  Chromosome 21 and down syndrome: from genomics to pathophysiology.

Authors:  Stylianos E Antonarakis; Robert Lyle; Emmanouil T Dermitzakis; Alexandre Reymond; Samuel Deutsch
Journal:  Nat Rev Genet       Date:  2004-10       Impact factor: 53.242

3.  NucPred--predicting nuclear localization of proteins.

Authors:  Markus Brameier; Andrea Krings; Robert M MacCallum
Journal:  Bioinformatics       Date:  2007-03-01       Impact factor: 6.937

4.  The consensus coding sequence (CCDS) project: Identifying a common protein-coding gene set for the human and mouse genomes.

Authors:  Kim D Pruitt; Jennifer Harrow; Rachel A Harte; Craig Wallin; Mark Diekhans; Donna R Maglott; Steve Searle; Catherine M Farrell; Jane E Loveland; Barbara J Ruef; Elizabeth Hart; Marie-Marthe Suner; Melissa J Landrum; Bronwen Aken; Sarah Ayling; Robert Baertsch; Julio Fernandez-Banet; Joshua L Cherry; Val Curwen; Michael Dicuccio; Manolis Kellis; Jennifer Lee; Michael F Lin; Michael Schuster; Andrew Shkeda; Clara Amid; Garth Brown; Oksana Dukhanina; Adam Frankish; Jennifer Hart; Bonnie L Maidak; Jonathan Mudge; Michael R Murphy; Terence Murphy; Jeena Rajan; Bhanu Rajput; Lillian D Riddick; Catherine Snow; Charles Steward; David Webb; Janet A Weber; Laurens Wilming; Wenyu Wu; Ewan Birney; David Haussler; Tim Hubbard; James Ostell; Richard Durbin; David Lipman
Journal:  Genome Res       Date:  2009-06-04       Impact factor: 9.043

5.  Systematic identification of cell cycle-dependent yeast nucleocytoplasmic shuttling proteins by prediction of composite motifs.

Authors:  Shunichi Kosugi; Masako Hasebe; Masaru Tomita; Hiroshi Yanagawa
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-11       Impact factor: 11.205

6.  Peripheral proteasome and caspase activity in Parkinson disease and Alzheimer disease.

Authors:  F Blandini; E Sinforiani; C Pacchetti; A Samuele; E Bazzini; R Zangaglia; G Nappi; E Martignoni
Journal:  Neurology       Date:  2006-02-28       Impact factor: 9.910

7.  Developmentally regulated expression of mtprd, the murine ortholog of tprd, a gene from the Down syndrome chromosomal region 1.

Authors:  C Lopes; M Rachidi; S Gassanova; P M Sinet; J M Delabar
Journal:  Mech Dev       Date:  1999-06       Impact factor: 1.882

8.  Inhibition of the ubiquitin-proteasome system in Alzheimer's disease.

Authors:  Y A Lam; C M Pickart; A Alban; M Landon; C Jamieson; R Ramage; R J Mayer; R Layfield
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-29       Impact factor: 11.205

9.  Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer's disease.

Authors:  T Chris Gamblin; Feng Chen; Angara Zambrano; Aida Abraha; Sarita Lagalwar; Angela L Guillozet; Meiling Lu; Yifan Fu; Francisco Garcia-Sierra; Nichole LaPointe; Richard Miller; Robert W Berry; Lester I Binder; Vincent L Cryns
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-29       Impact factor: 11.205

10.  The Down syndrome critical region protein TTC3 inhibits neuronal differentiation via RhoA and Citron kinase.

Authors:  Gaia Berto; Paola Camera; Carlo Fusco; Sara Imarisio; Chiara Ambrogio; Roberto Chiarle; Lorenzo Silengo; Ferdinando Di Cunto
Journal:  J Cell Sci       Date:  2007-05-08       Impact factor: 5.285

View more
  3 in total

Review 1.  TTC3-Mediated Protein Quality Control, A Potential Mechanism for Cognitive Impairment.

Authors:  Xu Zhou; Xiongjin Chen; Tingting Hong; Miaoping Zhang; Yujie Cai; Lili Cui
Journal:  Cell Mol Neurobiol       Date:  2021-02-27       Impact factor: 4.231

2.  BDdb: a comprehensive platform for exploration and utilization of birth defect multi-omics data.

Authors:  Dengwei Zhang; Si Zhou; Ziheng Zhou; Xiaosen Jiang; Dongsheng Chen; Hai-Xi Sun; Jie Huang; Shoufang Qu; Songchen Yang; Ying Gu; Xiuqing Zhang; Xin Jin; Ya Gao; Yue Shen; Fang Chen
Journal:  BMC Med Genomics       Date:  2021-11-04       Impact factor: 3.063

3.  AKT Hyperphosphorylation and T Cell Exhaustion in Down Syndrome.

Authors:  Daphne Peeters; Ingrid Pico-Knijnenburg; Douwe Wieringa; Mandana Rad; Roos Cuperus; Madelon Ruige; Frank Froeling; Gerda W Zijp; Mirjam van der Burg; Gertjan J A Driessen
Journal:  Front Immunol       Date:  2022-02-10       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.